Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2015-09-15Clinical Trial Update: Short Chain Fatty Acid Metabolism and Energy Metabolism [NA]
A completed clinical trial at Maastricht University Medical Center investigated short chain fatty acid metabolism and energy metabolism in i…
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: Community-based Sport Programme and Type 2 Diabetes [NA]
A clinical trial update on a community-based sport programme for adults with Type 2 diabetes; current status is UNKNOWN.
-
CLINICAL_TRIALS research · 2015-09-14Clinical Trial Update: Evaluation of the Metformin Effect on Methylglyoxal in Patients With Type 2 Diabetes [NA]
This clinical trial update discusses the evaluation of metformin's effect on methylglyoxal levels in patients with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS research · 2015-09-11Clinical Trial Update: MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without Diabetes [NA]
This clinical trial update evaluates the use of the Montreal Cognitive Assessment (MoCA) to detect mild cognitive impairment during annual a…
-
CLINICAL_TRIALS withdrawal · 2015-09-11Clinical Trial Update: Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1
A sub-study investigating how weight-loss surgery affects diabetes control has been withdrawn, involving gastric bypass and gastric banding …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-09-10FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA has granted a supplemental approval for insulin lispro submitted by Eli Lilly and Company.
-
FDA label_change · 2015-09-10FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVOKAMET (canagliflozin and metformin HCl) to update the product labeling.
-
FDA approval · 2015-09-09FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Invokana (canagliflozin) from Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Community Health Worker Reduces Care Utilization [Phase 4]
Phase 4 trial results indicate that deploying community health workers reduces healthcare utilization in patients with Type 2 Diabetes Melli…
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Walking Away: Structured Education Versus Written Information for Individuals With High Risk of Developing Type 2 Diabetes [NA]
A completed clinical trial comparing structured education versus written information for individuals at high risk of developing Type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Type 2 Diabetes Prevention [NA]
A completed clinical trial update on prevention of Type 2 diabetes (NCT02542722) is reported.
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Post-prandial Glucose and Insulin Levels in Type 2 Diabetes Mellitus Patients After Consumption of Ready-to-eat Mixed Meals [NA]
A completed clinical trial evaluated post-prandial glucose and insulin responses in patients with Type 2 diabetes mellitus after eating read…
-
CLINICAL_TRIALS research · 2015-09-07Clinical Trial Update: Day-Night Rhythm in Human Skeletal Muscle [NA]
This ClinicalTrials.gov study investigates day-night rhythm in human skeletal muscle in people with Type 2 diabetes mellitus and insulin res…
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients [Phase 3]
Phase 3 pharmacodynamic study comparing PL2200 against enteric-coated and immediate-release aspirin in patients with type 2 diabetes; result…
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients [Phase 3]
Phase 3 pharmacodynamic comparison of PL2200 versus enteric-coated aspirin in adults with type 2 diabetes; the trial status is completed and…
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Long Acting Insulin Glargine Titration Web Tool (LTHome) vs Enhanced Usual Therapy of Glargine Titration [NA]
A completed clinical trial comparing the LTHome titration web tool to enhanced usual titration for insulin glargine in Type 2 Diabetes Melli…
-
FDA approval · 2015-09-03FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for GLYBURIDE submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS research · 2015-09-03Clinical Trial Update: ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes) [Phase 2]
This document provides a Phase 2 clinical trial update for ARA-290, an erythropoietin analogue, in individuals with type 2 diabetes and rela…
-
FDA approval · 2015-09-02FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for GLYBURIDE submitted by Teva Pharmaceuticals USA, Inc. Glyburide is used to treat type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Beneficial Effects of a Polyphenol Enriched Beverage on Type 2 Diabetes Prevention and on Cardiovascular Risk Profile of Men and Women With Insulin Resistance. [NA]
A completed clinical trial reports that a polyphenol-enriched beverage may help prevent type 2 diabetes and improve cardiovascular risk fact…
-
FDA approval · 2015-09-01FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for a fixed-dose combination of dapagliflozin and metformin hydrochloride, manufactured by Prasco La…
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Psychoneuroimmunology Therapy in Uncontrolled Diabetic Patients: A Quasi-experimental Study [Phase 3]
Phase 3 quasi-experimental trial evaluating psychoneuroimmunology therapy in patients with uncontrolled Type 2 diabetes mellitus. The curren…
-
CLINICAL_TRIALS trial_result · 2015-08-31Clinical Trial Update: Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single Tablets [Phase 1]
A Phase 1 trial in healthy volunteers demonstrated bioequivalence of a fixed-dose combination tablet containing empagliflozin and metformin …
-
CLINICAL_TRIALS trial_result · 2015-08-31Clinical Trial Update: Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics [Phase 3]
This Phase 3 trial evaluated the impact of GLP-1 receptor agonists on cardiac function, epicardial adipose tissue volume, and myocardial tri…
-
FDA approval · 2015-08-28FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Januvia (sitagliptin) from Merck Sharp & Dohme LLC.